drugset / Trial / NCT00150696
Risedronate for the Prevention of Osteoporosis in People With Spinal Cord Injury.
Phase 3
Completed
38 enrolled
Toronto Rehabilitation Institute
Ontario Neurotrauma Foundation · collabQueen Elizabeth Hospital NHS Foundation Trust · collabSt. Joseph's Healthcare Foundation · collab
RandomizedParallel-groupDouble-blindPrevention
Summary
The purpose of this study is to find out if Risedronate works to prevent osteoporosis after spinal cord injury.
Timeline
- Start
- 2000-02
- Primary completion
- —
- Completion
- 2005-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Risedronate | Small molecule | — | — |